Citadel Advisors Reports a 5.2% Stake in NTST
Here’s The Hot Corner, with data through January 22, 2024:
Paradigm BioCapital Advisors LP filed a 13G for Tarsus Pharmaceuticals $TARS revealing an initial stake of 5.80%.
In the options market, there was bullish flow in QuantumScape Corporation $QS and Sea Limited $SE.
Stay tuned. We'll be back on Wednesday with more insider activity.
To have these insider transactions e-mailed to you every morning, sign up for The Hot Corner.
And please reach out with any questions. We love hearing from you!
All Star Charts Team